Long-standing basal cell carcinoma of the nasal wing in an elderly female
DOI:
https://doi.org/10.18203/2349-2902.isj20252688Keywords:
Basal cell carcinoma, Nasal lesion, Long-standing skin cancer, Mohs surgery, Facial reconstruction, Skin cancer management, Nasal tumor, Dermatologic oncologyAbstract
This case report describes a 75-year-old female with a long-standing basal cell carcinoma (BCC) of the left nasal wing, which had been present for approximately ten years. The lesion was characterized by a pigmented, irregular, plaque-like appearance with telangiectasias, and diagnosis was confirmed by biopsy. Surgical excision with reconstruction was planned to achieve complete tumor removal and restore nasal function. Managing BCC in the nasal area requires careful consideration to prevent potential complications such as tissue destruction, cartilage or bone invasion, and functional impairments, including nasal obstruction. The importance of early detection and the utilization of Mohs micrographic surgery as the preferred treatment option for high-risk or long-standing BCCs in cosmetically sensitive regions are emphasized. Long-term follow-up is crucial to detect recurrences and new skin malignancies, ensuring optimal outcomes.
Metrics
References
Nehal KS, Bichakjian CK. Update on Keratinocyte Carcinomas. N Eng J Med. 2018;379(4):363-74. DOI: https://doi.org/10.1056/NEJMra1708701
Kim JYS, Kozlow JH, Mittal B, Moyer J, Olencki T, Rodgers P. Guidelines of Care for the Management of Basal Cell Carcinoma. J Am Academy Dermatol. 2018;78(3):540-59. DOI: https://doi.org/10.1016/j.jaad.2017.10.006
Christopoulos G, Sergentanis TN, Karantonis F, Dimitrios K, Grigoris H, Epaminondas K, et al. Surgical Treatment and Recurrence of Cutaneous Nasal Malignancies: A 26-Year Retrospective Review of 1795 Patients. Ann Plastic Surg. 2016;77(2):e2-8. DOI: https://doi.org/10.1097/SAP.0000000000000329
Baba PUF, Hassan AU, Khurshid J, Wani AH. Basal Cell Carcinoma: Diagnosis, Management and Prevention. J Molecular Pathol. 2024;5(2):153-70. DOI: https://doi.org/10.3390/jmp5020010
Sim V, Thomas BR, Morris SL. Non-Melanoma Skin Cancer. In Treatment of Cancer. CRC Press. 2025;417-53. DOI: https://doi.org/10.1201/9781003433064-24
Kauvar AN, Cronin T, Roenigk R, Hruza G, Bennett R. Consensus for Nonmelanoma Skin Cancer Treatment: Basal Cell Carcinoma, Including a Cost Analysis of Treatment Methods. Dermatologic Surg. 2015;41(5):550-71. DOI: https://doi.org/10.1097/DSS.0000000000000296
Schmults CD, Blitzblau R, Aasi SZ, Alam M, Amini A, Bibee K, et al. Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J National Compreh Cancer Net. 2023;21(11):1181-203. DOI: https://doi.org/10.6004/jnccn.2023.0056
Ceder H. Enhancing the Management of High-Risk Basal Cell Carcinoma. Göteborgs universitet. 2025.
Daf AN, Kapse AS, Satsure MRG, Awthale MKG, Madavi MAN, Wanjari MDS, et al. Basal Cell Carcinoma: A Review. Int J Innovat Res Technol. 2024;11(2):1385-93.
Suzuki S, Kim SI, Barlow TK. Barriers to Mohs Micrographic Surgery in Japanese Patients With Basal Cell Carcinoma. Cutis. 2024;114(1):E16-20. DOI: https://doi.org/10.12788/cutis.1057
Kappelin J. Basal cell carcinoma-Epidemiology, risk factors, and outcome after surgical excision. Doctoral Thesis. 2024.
Downloads
Published
How to Cite
Issue
Section
